| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Rabeprazole Impurity 17 |
BAZEDOXIFENE-N-OXIDE |
1174289-22-5 |
詳細(xì)
|
| Dolutegravir Impurity 17 |
MK-3102中間體3 |
1280210-80-1 |
詳細(xì)
|
| Dolutegravir Impurity 16 |
1-叔丁氧碳基-3-吡咯烷酮 |
101385-93-7 |
詳細(xì)
|
| Dolutegravir Impurity 11 |
表氰醇 |
624-58-8 |
詳細(xì)
|
| porphine Impurity 1 |
3-甲基-5-羥基-2-(4-羥基苯基)-1H-吲哚 |
91444-54-1 |
詳細(xì)
|
| Piperonal Impurity 3 |
2,4,5,6-四氫吡咯并[3,4-C]吡唑 |
6573-19-9 |
詳細(xì)
|
| *Eugenol Impurity 16 (Eugenol EP Impurity P) |
異戊酸鈉 |
539-66-2 |
詳細(xì)
|
| Abiraterone Impurity 2 (Abiraterone Acetate Beta-Epoxide) |
2-羥基丙基乙酸酯 |
627-69-0 |
詳細(xì)
|
| Loxoprofen Impurity 75 |
1-羥基丙-2-基乙酸酯 |
6214-01-3 |
詳細(xì)
|
| Felbinac Impurity 5 |
萘-1,4-二醇,1-鄰-乙?；?2-甲基- |
2211-27-0 |
詳細(xì)
|
| Sodium Isovalerate |
(+)-Phytone |
16825-16-4 |
詳細(xì)
|
| Elagolix Impurity 41 |
SUCROSE 1,6,6'-TRICARBOXYLATE TRIMETHYL ESTER |
289711-92-8 |
詳細(xì)
|
| Sofosbuvir Impurity 75 |
帕唑帕尼雜質(zhì)27 |
936939-36-5 |
詳細(xì)
|
| Phytonadione Impurity 29 |
2-羥基-4-甲硫基丁酰胺 |
49540-21-8 |
詳細(xì)
|
| Sofosbuvir Impurity 124 |
2-羥基-4-(甲硫基)丁腈 |
17773-41-0 |
詳細(xì)
|
| Sofosbuvir Impurity 125 |
5-(1-羥基-2-甲基丙基)海因 |
99669-71-3 |
詳細(xì)
|
| Sofosbuvir Impurity 95 |
乙酰半胱氨酸雜質(zhì)37 |
155172-79-5 |
詳細(xì)
|
| Levetiracetam Impurity 47 |
阿立哌唑二聚物雜質(zhì)前體 |
784135-99-5 |
詳細(xì)
|
| Sucrose Impurity 12 |
雙(二亞芐基丙酮)鈀 |
32005-36-0 |
詳細(xì)
|
| Sucrose Impurity 14 |
丙炔酸甲酯 |
922-67-8 |
詳細(xì)
|
| Tolvaptan Impurity 13 |
安賽蜜 |
33665-90-6 |
詳細(xì)
|
| Tolvaptan Impurity 14 |
BETA-D-[1-13C]FRUCTOFURANOSYL ALPHA-D-GLUCOPYRANOSIDE |
154368-11-3 |
詳細(xì)
|
| Azathioprine Impurity 11 |
6,1',6'-tri-O-tribenzylsucrose |
35674-14-7 |
詳細(xì)
|
| Tizanidine Impurity 12 |
3,4-di-O-acetyl-1,6,6'-tri-O-tribenzylsucrose triacetate |
35867-26-6 |
詳細(xì)
|
| Tolvaptan Impurity 12 |
2-乙基-1,3-己二醇 |
94-96-2 |
詳細(xì)
|
| Cefdinir Impurity 35 |
N-(2-BENZOYL-4-CHLOROPHENYL)FORMAMIDE |
10352-28-0 |
詳細(xì)
|
| Dolutegravir Impurity 9 |
卡比多巴相關(guān)物質(zhì)A |
85933-19-3 |
詳細(xì)
|
| Felbinac Impurity 6 |
4,4'-二苯醚二甲酸 |
2215-89-6 |
詳細(xì)
|
| Sucrose Impurity 15 |
R-(+)-1,1'-聯(lián)萘-2,2'-雙二苯膦 |
76189-55-4 |
詳細(xì)
|
| Sucrose Impurity 16 |
1,1'-聯(lián)萘-2,2'-雙二苯膦 (BINAP) |
98327-87-8 |
詳細(xì)
|
| Sucrose Impurity 17 |
N1,N2-二(呋喃-2-基甲基)氧醛酰胺 |
69010-90-8 |
詳細(xì)
|
| Sucrose Impurity 20 |
盧非酰胺雜質(zhì) |
106308-60-5 |
詳細(xì)
|
| Sucrose Impurity 22 |
2,6-二氟氯芐 |
697-73-4 |
詳細(xì)
|
| Memantine Impurity 23 |
蔗糖八硫酸酯三乙銨鹽 |
869561-07-9 |
詳細(xì)
|
| Sucrose Impurity 21 |
蔗糖棕櫚酸酯 |
26446-38-8 |
詳細(xì)
|
| Duloxetine Impurity 32 |
蔗糖硬脂酸酯 |
25168-73-4 |
詳細(xì)
|
| Elagolix Impurity 42 |
Sucrose 4,6-Methyl Orthoester |
116015-72-6 |
詳細(xì)
|
| Duloxetine Impurity 31 |
Sucrose 6’Carboxylic Acid |
133634-69-2 |
詳細(xì)
|
| Morphothiadin Impurity 1 |
Sucrose 6,6’Dicarboxylic Acid |
133634-70-5 |
詳細(xì)
|
| Memantine Impurity 21 |
蔗糖癸酸酯 |
31835-06-0 |
詳細(xì)
|
| Memantine Impurity 22 |
蔗糖十二烷酸酯 |
25339-99-5 |
詳細(xì)
|
| Sildenafil Impurity 22 |
(3,4-二羥基-5-(羥甲基)-5-((3,4,5-三羥基-6-(羥甲基)四氫-2H-吡喃-2-基)氧基)四氫呋喃-2-基)甲基二氫磷酸鹽、鉀鹽 |
36064-19-4 |
詳細(xì)
|
| Rivastigmine Impurity 46 |
sucrose octasulfate |
57680-56-5 |
詳細(xì)
|
| Rapamycin Impurity 28 |
4-O-B-D-半乳糖苷蔗糖 |
87419-56-5 |
詳細(xì)
|
| Rapamycin Impurity 29 |
6-Carboxysucrose |
133634-68-1 |
詳細(xì)
|
| Rapamycin Impurity 30 |
B-D-呋喃果糖基Α-D-吡喃葡萄糖苷6-辛酸酯 |
13039-39-9 |
詳細(xì)
|
| Nicotinic Acid Impurity 19 |
蔗糖八硫酸酯鈉 |
74135-10-7 |
詳細(xì)
|
| *Nicotinic Acid Impurity 7 (Nicotinic Acid EP Impurity G) |
SUCROSE OCTASULFATE, AMMONIUM SALT |
74135-13-0 |
詳細(xì)
|
| *Ceftazidime Impurity 6（Ceftazidime EP Impurity F） |
蔗糖-6-乙酸酯 |
936001-72-8 |
詳細(xì)
|
| Sucrose Impurity 7 |
羥乙基乙二胺 |
111-41-1 |
詳細(xì)
|
| Sucrose Impurity 9 |
三乙烯二胺 |
280-57-9 |
詳細(xì)
|
| Sucrose Impurity 11 |
鄰碘溴苯 |
583-55-1 |
詳細(xì)
|
| Sucrose Impurity 6 |
2,4-二甲基苯磺酸 |
88-61-9 |
詳細(xì)
|
| Sucrose Impurity 4 |
甲氧基乙酰氯 |
38870-89-2 |
詳細(xì)
|
| Omarigliptin Impurity 18 |
卡巴拉汀 RC 1 |
923035-06-7 |
詳細(xì)
|
| Omarigliptin Impurity 15 |
埃索美拉唑雜質(zhì)31 |
1114596-75-6 |
詳細(xì)
|
| Sacubitril Impurity 89 |
1-硝基丙三醇 |
624-43-1 |
詳細(xì)
|
| Picaridin Impurity 7 |
二氯磷酸苯酯 |
770-12-7 |
詳細(xì)
|
| Acyclovir Impurity 31 |
(2S,4S,5S)-2-[(2S,4R,5R)-2,5-bis[dideuterio(hydroxy)methyl]-3,4-dihydroxyoxolan-2-yl]oxy-6-[dideuterio(hydroxy)methyl]oxane-3,4,5-triol |
955943-30-3 |
詳細(xì)
|
| Sucrose Impurity 24 |
帕唑帕尼雜質(zhì)41 |
35122-82-8 |
詳細(xì)
|
| Cypermethrin Impurity 5 |
芐蚨菊酯 |
10453-86-8 |
詳細(xì)
|
| Cypermethrin Impurity 6 |
生物芐呋菊酯 |
28434-01-7 |
詳細(xì)
|
| Cypermethrin Impurity 7 |
對(duì)甲氧基肉桂酸辛酯 |
5466-77-3 |
詳細(xì)
|
| Cypermethrin Impurity 8 |
印楝素 |
11141-17-6 |
詳細(xì)
|
| Cypermethrin Impurity 9 |
印楝素B |
106500-25-8 |
詳細(xì)
|
| Cypermethrin Impurity 10 |
Azadirachtin D |
99399-65-2 |
詳細(xì)
|
| Cypermethrin Impurity 11 |
印楝素H |
134788-15-1 |
詳細(xì)
|
| Crizotinib Impurity 2 |
2,4,6-三氟苯甲酰胺 |
82019-50-9 |
詳細(xì)
|
| Rebamipide Impurity 8 |
5' 氨基TFA |
133975-85-6 |
詳細(xì)
|
| Erlotinib Impurity 134 |
多非利特-D4 |
1189700-56-8 |
詳細(xì)
|
| Azadirachtin D |
多替拉韋雜質(zhì)4 |
1863916-88-4 |
詳細(xì)
|
| Azadirachtin H |
1-(2,2-二甲氧基乙基)-1,4-二氫-3-甲氧基-4-氧代-2,5-吡啶二甲酸 2-甲酯 |
1335210-23-5 |
詳細(xì)
|
| Azadirachtin I |
Dolutegravir Impurity 7 |
2244161-71-3 |
詳細(xì)
|
| Syringaresinol Impurity 1(Syringaresinol Diglucoside) |
杜魯特韋雜質(zhì)8 |
1802141-49-6 |
詳細(xì)
|
| Moxifloxacin Impurity 11 Monomer |
DEAMIDO NAD SODIUM SALT |
104809-30-5 |
詳細(xì)
|
| Metamitron Impurity 3 |
sodium phenyl sulfate |
14276-99-4 |
詳細(xì)
|
| Deferasirox Impurity 20 |
雷帕霉素(西羅莫司)雜質(zhì)30 |
144370-88-7 |
詳細(xì)
|
| Azadirachtin B |
(4R,12AS)-N-(2,4-二氟芐基)-7-苯氧基-4-甲基-6,8-二氧-3,4,6,8,12,12A-六氫-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷-9-甲酰胺 |
1206102-11-5 |
詳細(xì)
|
| Lecithin Impurity 7 |
多非利特雜質(zhì) |
115256-14-9 |
詳細(xì)
|
| Posaconazole Impurity 131 |
多非利特雜質(zhì)E |
937195-06-7 |
詳細(xì)
|
| Thiamine Impurity 2 (Thiamine EP Impurity B HBr) |
多非利特雜質(zhì)D |
937194-99-5 |
詳細(xì)
|
| Pranoprofen Impurity 15 |
多非利特雜質(zhì)F |
312315-47-2 |
詳細(xì)
|
| Abiraterone Impurity 73 |
|
937195-03-4 |
詳細(xì)
|
| Salbutamol Impurity 65 |
Dofetilide N`-Nitryl Impurity |
115256-44-5 |
詳細(xì)
|
| Salbutamol Impurity 66 |
Dofetilide N-Nitryl Impurity |
115256-45-6 |
詳細(xì)
|
| Vildagliptin Impurity 87 |
1,3-二氫-4-甲基-2H-1,5-苯并二氮雜革-2-酮 |
6276-48-8 |
詳細(xì)
|
| Solifenacin Impurity 27 |
N-甲基-N-(4-氨基苯氧乙基)-4-氨基苯乙胺 |
115256-13-8 |
詳細(xì)
|
| Dofetilide Impurity 11 |
1-溴金剛烷 |
768-90-1 |
詳細(xì)
|
| Dofetilide Impurity 12 |
1,3,5-三甲基金剛烷 |
707-35-7 |
詳細(xì)
|
| Crizotinib Impurity 1 |
6-溴-2,2'-聯(lián)吡啶 |
10495-73-5 |
詳細(xì)
|
| Lurasidone Impurity 3 HCl |
6,6'-二氨基-2,2'-聯(lián)吡啶 |
93127-75-4 |
詳細(xì)
|
| Risedronate Impurity 12 |
2,3,4,5-四氫-7,8-二硝基-3-(三氟乙酰基)-1,5-甲橋-1H-3-苯并氮雜卓 |
230615-59-5 |
詳細(xì)
|
| Cypermethrin Impurity 15 |
(+)-丁香樹脂酚 |
21453-69-0 |
詳細(xì)
|
| Cypermethrin Impurity 14 |
刺五加甙E |
96038-87-8 |
詳細(xì)
|
| Cypermethrin Impurity 13 |
(-)-丁香脂素 |
6216-81-5 |
詳細(xì)
|
| Cypermethrin Impurity 12 |
|
134788-16-2 |
詳細(xì)
|
| Cypermethrin Impurity 16 |
環(huán)阿屯醇 |
469-38-5 |
詳細(xì)
|
| Vildagliptin-13C5,15N |
氟班色林雜質(zhì) |
60568-46-9 |
詳細(xì)
|
| Aminocaproic Acid Impurity 16 |
二氫吡啶 |
1149-23-1 |
詳細(xì)
|
| Fenamiphos Impurity 4 |
多非利特雜質(zhì) |
115256-12-7 |
詳細(xì)
|